Loading...
Derniers dépôts
-
Hans-Jürgen Kreienkamp, Matias Wagner, Heike Weigand, Allyn Mcconkie-Rossell, Marie Mcdonald, et al.. Variant-specific effects define the phenotypic spectrum of HNRNPH2-associated neurodevelopmental disorders in males. Human Genetics, 2021, 141 (2), pp.257-272. ⟨10.1007/s00439-021-02412-x⟩. ⟨hal-04522950⟩
-
Andrea I Luppi, Joana Cabral, Rodrigo Cofre, Pedro A.M. Mediano, Fernando E Rosas, et al.. Computational modelling in disorders of consciousness: Closing the gap towards personalised models for restoring consciousness. NeuroImage, 2023, 275, pp.120162. ⟨10.1016/j.neuroimage.2023.120162⟩. ⟨hal-04522925⟩
-
Justin T Jordan, Christina C Orr, Raquel D Thalheimer, Josephine V Cambillo, Roberta L Beauchamp, et al.. Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neuro-Oncology Advances, 2023, 5 (1), pp.vdad041. ⟨10.1093/noajnl/vdad041⟩. ⟨hal-04522875⟩
-
Benoit Souchet, Alkéos Michaïl, Maud Heuillet, Aude Dupuy‐gayral, Eloi Haudebourg, et al.. Multiomics Blood Biomarkers Predict Alzheimer from predementia with High Specificity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2023, 19 (S24), pp.e082707. ⟨10.1002/alz.082707⟩. ⟨hal-04522821⟩
-
Laurent Cleret de Langavant, Eléonore Bayen, Anne‐catherine Bachoud-Lévi, Kristine Yaffe. Approximating dementia prevalence in population‐based surveys of aging worldwide: An unsupervised machine learning approach. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020, 6 (1), pp.e12074. ⟨10.1002/trc2.12074⟩. ⟨hal-04521391⟩